Edition:
India

Luye Pharma Group Ltd (2186.HK)

2186.HK on Hong Kong Stock

6.65HKD
9:26am IST
Change (% chg)

HK$-0.08 (-1.19%)
Prev Close
HK$6.73
Open
HK$6.80
Day's High
HK$6.81
Day's Low
HK$6.65
Volume
7,964,500
Avg. Vol
19,738,636
52-wk High
HK$7.37
52-wk Low
HK$3.95

Chart for

About

Luye Pharma Group Ltd. is an investment holding company principally engaged in the development, production, marketing and sale of pharmaceutical products. The Company operates its business mainly in Mainland China. The Company operates its business through four segments: Oncology Drugs segment, Cardiovascular System Drugs... (more)

Overall

Beta: --
Market Cap(Mil.): HK$15,675.47
Shares Outstanding(Mil.): 3,321.07
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Luye Pharma Group‍ Announces Update on Patent Litigation Regarding Rivastigmine 1 Day Patch

* COURT OF APPEAL FOR DISTRICT OF MUNICH, GERMANY DISMISSES APPEAL FROM NOVARTIS AG AS CLAIMANT IN PATENT INFRINGEMENT LAWSUIT

28 Dec 2017

BRIEF-Luye Pharma Says ‍Unit Applies To Register For Proposed Issue Of Debt Securities

* ‍UNIT APPLIES TO NATIONAL ASSOCIATION OF FINANCIAL MARKET INSTITUTIONAL INVESTORS TO REGISTER FOR PROPOSED ISSUE OF DEBT SECURITIES

19 Dec 2017

BRIEF-Luye Pharma repurchases 6.6 mln shares

* Repurchased 6.6 million ordinary shares of company Source text for Eikon: Further company coverage:

04 Sep 2017

BRIEF-Luye Pharma Group says HY profit attributable fell 9.2 pct

* HY profit attributable to shareholders fell 9.2 pct to RMB385.4 million

28 Aug 2017

BRIEF-Luye Pharma Group's unit to buy two biological antibody products

* SHANDONG LUYE and Shandong Boan Biological Technology Co entered into asset transfer agreements

04 Aug 2017

Earnings vs. Estimates